{
    "root": "74974eef-499f-456f-8683-da23bb0c1137",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Colchicine",
    "value": "20250327",
    "ingredients": [
        {
            "name": "COLCHICINE",
            "code": "SML2Y3J35T"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        }
    ],
    "indications": "colchicine tablets , usp alkaloid indicated : prophylaxis treatment gout flares adults ( 1.1 ) . familial mediterranean fever ( fmf ) adults children 4 years older ( 1.2 ) .",
    "contraindications": "long-term colchicine , usp established fmf prophylaxis gout flares , safety efficacy repeat treatment gout flares evaluated . dosing regimens colchicine tablets , usp different indication must individualized . recommended colchicine tablets , usp depends patient \u2019 age , renal function , hepatic function co-administered drugs [ ( 2.4 , 2.5 , 2.6 ) ] . colchicine tablets , usp administered orally without regard meals . colchicine tablets , usp analgesic medication used treat pain causes .",
    "warningsAndPrecautions": null,
    "adverseReactions": "patients renal hepatic impairment given colchicine , usp conjunction p-gp strong cyp3a4 inhibitors ( includes protease inhibitors except fosamprenavir ) . patients , life-threatening fatal colchicine , usp toxicity reported colchicine , usp taken therapeutic doses .",
    "indications_original": "Colchicine tablets, USP are an alkaloid indicated for: Prophylaxis and treatment of gout flares in adults ( 1.1 ). Familial Mediterranean fever (FMF) in adults and children 4 years or older (1.2) .",
    "contraindications_original": "The long-term use of colchicine, USP is established for FMF and the prophylaxis of gout flares, but the safety and efficacy of repeat treatment for gout flares has not been evaluated. The dosing regimens for colchicine tablets, USP are different for each indication and must be individualized. \n                  The recommended dosage of colchicine tablets, USP depends on the patient\u2019s age, renal function, hepatic function and use of co-administered drugs [see Dosage and Administration (2.4, 2.5, 2.6)]\n                     . \n                  \n                  Colchicine tablets, USP are administered orally without regard to meals.\n                  Colchicine tablets, USP are not an analgesic medication and should not be used to treat pain from other causes.",
    "adverseReactions_original": "Patients with renal or hepatic impairment should not be given colchicine, USP in conjunction with P-gp or strong CYP3A4 inhibitors (this includes all protease inhibitors except fosamprenavir). In these patients, life-threatening and fatal colchicine, USP toxicity has been reported with colchicine, USP taken in therapeutic doses."
}